Transformative Science Coupled With Unique kojoX™ Operational Ecosystem
The Keys to Achieving Unparalleled Flexibility in CHO Based Bioproduction
Keeping pace with the surging global demand for medicines is one of the largest challenges facing the bioprocessing industry today. The dynamic growth and pace of change observed in novel monoclonal antibody formats plus cell and gene therapies emphasizes that biomanufacturing innovation is essential to deliver the scale, speed, and sustainability needed for the future. FUJIFILM Biotechnologies is revolutionizing the bioprocessing industry – through our unique, globally harmonized operational ecosystem termed kojoX™ that brings our partners flexibility and unmatched speed to market. While harnessing transformative science and innovation via strategic partnerships with world leading universities and through Fujifilm’s Innovation Center of Excellence at the Bioscience and Engineering Laboratory (BSEL) near Tokyo in Japan – ultimately working to the end goal of making the life changing therapies of tomorrow more accessible and affordable. Learn more in this white paper by Leon Pybus Ph.D., Associate Director Cell Culture Process Development, FUJIFILM Biotechnologies.